Veracyte to Participate in the Stephens Annual Investment Conference
November 02 2023 - 8:15AM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT) announced today that Rebecca
Chambers, chief financial officer, will participate in a fireside
chat at the Stephens Annual Investment Conference on Wednesday,
November 15, at 3:00 p.m. Eastern Time.
A live audio webcast of the company’s presentations will be
available by visiting Veracyte’s website at
http://investor.veracyte.com/events-presentations. A replay of the
webcasts will be available for 90 days following the conclusion of
the live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose
vision is to transform cancer care for patients all over the world.
We empower clinicians with the high-value insights they need to
guide and assure patients at pivotal moments in the race to
diagnose and treat cancer. Our high-performing tests enable
clinicians to make more confident diagnostic, prognostic and
treatment decisions for some of the most challenging diseases such
as thyroid, prostate, breast, bladder and lung cancers, as well as
interstitial lung diseases. We help patients avoid unnecessary
procedures and speed time to diagnosis and appropriate treatment.
In addition to making our tests available in the U.S. through our
central laboratories, we also aim to deliver our tests to patients
worldwide through a distributed model to laboratories that can
perform them locally. Veracyte is based in South San Francisco,
California. For more information, please visit www.veracyte.com and
follow the company on Twitter (@veracyte).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231102373163/en/
Investors: investors@veracyte.com 619-393-1545
Media: Tracy Morris Vice President of Global Corporate
Communications tracy.morris@veracyte.com 650-380-4413
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Apr 2024 to May 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From May 2023 to May 2024